Similar companies
| Company | Employee Rating | |
|---|---|---|
 |
AmgenAMGN |
76 0% |
 |
Gilead SciencesGILD |
72 0% |
 |
Catalyst PharmaceuticalsCPRX |
92 0% |
 |
Inovio PharmaceuticalsINO |
66 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
What Do NeuroSense Therapeutics Employees Think? NeuroSense Therapeutics’s Glassdoor Score
NeuroSense Therapeutics (NRSN) has a Glassdoor employee rating of 88/100, based on anonymous employee reviews covering workplace culture, compensation, management, and career opportunities. This is a strong rating, placing NeuroSense Therapeutics among the better-rated employers in the Biotechnology sector. High employee satisfaction is often associated with lower turnover, stronger execution, and steadier long-term performance.
The rating has held broadly steady over the past three months.
At 88/100, NeuroSense Therapeutics’s employee rating ranks ahead of industry peers like Amgen (76/100) and Gilead Sciences (72/100).
Is NeuroSense Therapeutics a Good Place to Work?
A 88/100 rating is strong — NeuroSense Therapeutics is among the better-rated employers in its sector, pointing to high workplace satisfaction. Employee satisfaction has been linked to lower turnover and stronger execution, so a well-regarded workplace can be a quiet tailwind for the business. For the full employment picture, see NeuroSense Therapeutics’s employee business outlook (forward-looking sentiment), job postings (hiring momentum), and LinkedIn headcount (workforce size).
Why NeuroSense Therapeutics’s Employee Rating Matters for NRSN Stock
Employee satisfaction is a leading indicator: the people inside the business feel culture, management, and morale shifts before they surface in an earnings report. AltIndex feeds NeuroSense Therapeutics’s employee rating into the NRSN AI Score as one of 25+ alternative data signals, weighed alongside the rest of the employment cluster, fundamentals, and more. It also pairs with insider activity for a read on how both employees and executives view the company.
NeuroSense Therapeutics Employee Rating: Frequently Asked Questions
NeuroSense Therapeutics (NRSN) has a Glassdoor employee rating of 88/100. It is based on anonymous employee reviews covering workplace culture, compensation, management, and career opportunities, and AltIndex updates it regularly.
A 88/100 rating is strong — NeuroSense Therapeutics is among the better-rated employers in its sector, pointing to high workplace satisfaction.
No single signal predicts a stock on its own, but employee rating can be a leading indicator: satisfaction is linked to lower turnover and better execution, and morale tends to shift before it shows up in earnings. That is why AltIndex combines it with the rest of the employment cluster and 20+ other signals in the NRSN AI Score rather than reading any one signal in isolation.
NeuroSense Therapeutics overperforms a majority of its industry peers when it comes to Employee Rating, ranking in the 88th percentile.
AltIndex updates NeuroSense Therapeutics' employee ratings every month. This regular update schedule ensures that investors have access to the latest information, reflecting any recent changes in employee sentiment or internal company dynamics.
Sign up and get more insights on NeuroSense Therapeutics.
See NeuroSense Therapeutics’s complete employee rating history
Sign up to unlock 1-year and all-time charts for NRSN, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
